High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers—Preliminary results
✍ Scribed by Ashwatha Narayana; Gil'ad N. Cohen; Marco Zaider; Kelvin Chan; Nancy Lee; Richard J. Wong; Jay Boyle; Ashok Shaha; Dennis Kraus; Jatin Shah; Michael J. Zelefsky
- Book ID
- 108074776
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 784 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1538-4721
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background. The literature is scarce regarding the use of interstitial high‐dose‐rate brachytherapy (I‐HDR) as adjuvant treatment of the cervical region, and most reports are focused on primary tumors of the mobile tongue and oropharynx. We evaluated the outcome and morbidity relate
Background. Recurrent head and neck malignancies are therapeutically challenging. Brachytherapy is a retreatment alternative to external-beam radiation therapy (EBRT). Methods. Patients receiving brachytherapy during 1987-2004 for recurrent head and neck cancer were identified. Tumor and treatment